| Dr Luis Fernando Gonzalez, MD | |
|
1800 Orleans St # 6115e, Baltimore, MD 21287-0010 | |
| (410) 955-2438 | |
| (443) 287-0339 |
| Full Name | Dr Luis Fernando Gonzalez |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 31 Years |
| Location | 1800 Orleans St # 6115e, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053591024 | NPI | - | NPPES |
| 102366468 | Medicaid | PA | |
| 0205613 | Medicaid | NJ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Johns Hopkins Bayview Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
Lung cancers account for approximately 25 percent of all cancer deaths. Even among those who do not smoke, 1 in 15 men and 1 in 17 women are expected to develop lung cancer in their lifetime, according to the American Cancer Society.
Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the United States Food and Drug Administration for the potential treatment of patients with breast cancer.
Researchers from the University of Auckland, New Zealand, have discovered that a potent new drug restores hearing after noise-induced hearing loss in rats. The landmark discovery found that injection of an agent called 'ADAC', activates adenosine receptors in cochlear tissues, resulting in recovery of hearing function. The finding paves the way for effective non-surgical therapies to restore hearing loss after noise-induced injury. Dr. Srdjan Vlajkovic and his team's work1 is published in a special edition of Springer's journal Purinergic Signalling, focusing on the inner ear.
Researchers at UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have discovered a mechanism in adult stem cells by which the cells suppress their ability to initiate cancer during their dormant phase, an understanding that could be exploited for better cancer prevention strategies.
The novel coronavirus pandemic forced many countries into lockdown, requiring people to stay at home to prevent the spread of the deadly severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The dramatic change to life has left many people in distress, affecting psychological and emotional wellbeing.
› Verified 7 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
Lung cancers account for approximately 25 percent of all cancer deaths. Even among those who do not smoke, 1 in 15 men and 1 in 17 women are expected to develop lung cancer in their lifetime, according to the American Cancer Society.
Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the United States Food and Drug Administration for the potential treatment of patients with breast cancer.
Researchers from the University of Auckland, New Zealand, have discovered that a potent new drug restores hearing after noise-induced hearing loss in rats. The landmark discovery found that injection of an agent called 'ADAC', activates adenosine receptors in cochlear tissues, resulting in recovery of hearing function. The finding paves the way for effective non-surgical therapies to restore hearing loss after noise-induced injury. Dr. Srdjan Vlajkovic and his team's work1 is published in a special edition of Springer's journal Purinergic Signalling, focusing on the inner ear.
Researchers at UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have discovered a mechanism in adult stem cells by which the cells suppress their ability to initiate cancer during their dormant phase, an understanding that could be exploited for better cancer prevention strategies.
The novel coronavirus pandemic forced many countries into lockdown, requiring people to stay at home to prevent the spread of the deadly severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The dramatic change to life has left many people in distress, affecting psychological and emotional wellbeing.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Luis Fernando Gonzalez, MD 6201 Greenleigh Ave, Baltimore, MD 21220-2004 Ph: (410) 933-6423 | Dr Luis Fernando Gonzalez, MD 1800 Orleans St # 6115e, Baltimore, MD 21287-0010 Ph: (410) 955-2438 |
News Archive
Lung cancers account for approximately 25 percent of all cancer deaths. Even among those who do not smoke, 1 in 15 men and 1 in 17 women are expected to develop lung cancer in their lifetime, according to the American Cancer Society.
Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the United States Food and Drug Administration for the potential treatment of patients with breast cancer.
Researchers from the University of Auckland, New Zealand, have discovered that a potent new drug restores hearing after noise-induced hearing loss in rats. The landmark discovery found that injection of an agent called 'ADAC', activates adenosine receptors in cochlear tissues, resulting in recovery of hearing function. The finding paves the way for effective non-surgical therapies to restore hearing loss after noise-induced injury. Dr. Srdjan Vlajkovic and his team's work1 is published in a special edition of Springer's journal Purinergic Signalling, focusing on the inner ear.
Researchers at UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have discovered a mechanism in adult stem cells by which the cells suppress their ability to initiate cancer during their dormant phase, an understanding that could be exploited for better cancer prevention strategies.
The novel coronavirus pandemic forced many countries into lockdown, requiring people to stay at home to prevent the spread of the deadly severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The dramatic change to life has left many people in distress, affecting psychological and emotional wellbeing.
› Verified 7 days ago
Dr. Whitney Erin Parker, MD, PHD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 600 N Wolfe Street, Phipps 554, Baltimore, MD 21287 Phone: 410-955-7851 Fax: 410-367-3255 | |
Kimberly Ashayeri, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 600 N Wolfe Street, Meyer 7-113, Baltimore, MD 21287 Phone: 443-287-4934 Fax: 410-502-3399 | |
Dr. Richard Louis Cohen, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Cornelius Ct, Baltimore, MD 21208 Phone: 410-764-3100 | |
Dr. William Wallace Ashley Jr., M.D., PH.D., M.B.A. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5051 Greenspring Ave, Suite 300, Baltimore, MD 21209 Phone: 410-601-4417 Fax: 410-601-7138 | |
Dr. James Edmond Conway, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5051 Greenspring Ave, Suite 101, Baltimore, MD 21209 Phone: 410-664-3680 Fax: 410-664-3686 | |
Dr. Daniel Michael Sciubba, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Meyer Building 8-161, Baltimore, MD 21287 Phone: 410-491-8330 Fax: 410-502-5768 | |
Hatem S Abdo, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 19 Fontana Ln, Ste 206, Baltimore, MD 21237 Phone: 410-391-6904 Fax: 410-686-6640 |